Senior insider sale
SVP, General Counsel at SAREPTA THERAPEUTICS, INC. — senior position signals high conviction
$284.6K
2.27K shares
What this filing means
BROWN RYAN EDWARD plans to sell 2.27K shares of SAREPTA THERAPEUTICS, INC. valued at approximately $284.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/1/2024ACC: 0001972362-24-000284
Officer· SVP, General Counsel
Since Feb 2021
2.27K
Shares to sell
$284.6K
Approx. market value
2.27K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
RESTRICTED STOCK
COMPENSATION
3/3/2023
2KRESTRICTED STOCK
COMPENSATION
2/28/2020
269.00Total acquired2.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2023 | RESTRICTED STOCK COMPENSATION | 2K | — |
2/28/2020 | RESTRICTED STOCK COMPENSATION | 269.00 | — |
| Total | 2.27K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.27K
Market value
$284.6K
3/1/2024
Total
Units
2.27K
Value
$284.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/1/2024 | 2.27K | $284.6K | NASDAQ | Planned |
| Total | 2.27K | $284.6K | ||